scholarly journals Towards Profiling of the G-Quadruplex Targeting Drugs in the Living Human Cells Using NMR Spectroscopy

2021 ◽  
Vol 22 (11) ◽  
pp. 6042
Author(s):  
Daniel Krafčík ◽  
Eva Ištvánková ◽  
Šimon Džatko ◽  
Pavlína Víšková ◽  
Silvie Foldynová-Trantírková ◽  
...  

Recently, the 1H-detected in-cell NMR spectroscopy has emerged as a unique tool allowing the characterization of interactions between nucleic acid-based targets and drug-like molecules in living human cells. Here, we assess the application potential of 1H and 19F-detected in-cell NMR spectroscopy to profile drugs/ligands targeting DNA G-quadruplexes, arguably the most studied class of anti-cancer drugs targeting nucleic acids. We show that the extension of the original in-cell NMR approach is not straightforward. The severe signal broadening and overlap of 1H in-cell NMR spectra of polymorphic G-quadruplexes and their complexes complicate their quantitative interpretation. Nevertheless, the 1H in-cell NMR can be used to identify drugs that, despite strong interaction in vitro, lose their ability to bind G-quadruplexes in the native environment. The in-cell NMR approach is adjusted to a recently developed 3,5-bis(trifluoromethyl)phenyl probe to monitor the intracellular interaction with ligands using 19F-detected in-cell NMR. The probe allows dissecting polymorphic mixture in terms of number and relative populations of individual G-quadruplex species, including ligand-bound and unbound forms in vitro and in cellulo. Despite the probe’s discussed limitations, the 19F-detected in-cell NMR appears to be a promising strategy to profile G-quadruplex–ligand interactions in the complex environment of living cells.

2017 ◽  
Vol 45 (9) ◽  
pp. 5501-5511 ◽  
Author(s):  
Hong-Liang Bao ◽  
Takumi Ishizuka ◽  
Takashi Sakamoto ◽  
Kenzo Fujimoto ◽  
Tamayo Uechi ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Dilan Boodhai Jaunky ◽  
Kevin Larocque ◽  
Mathieu C. Husser ◽  
Jiang Tian Liu ◽  
Pat Forgione ◽  
...  

AbstractWe reveal the effects of a new microtubule-destabilizing compound in human cells. C75 has a core thienoisoquinoline scaffold with several functional groups amenable to modification. Previously we found that sub micromolar concentrations of C75 caused cytotoxicity. We also found that C75 inhibited microtubule polymerization and competed with colchicine for tubulin-binding in vitro. However, here we found that the two compounds synergized suggesting differences in their mechanism of action. Indeed, live imaging revealed that C75 causes different spindle phenotypes compared to colchicine. Spindles remained bipolar and collapsed after colchicine treatment, while C75 caused bipolar spindles to become multipolar. Importantly, microtubules rapidly disappeared after C75-treatment, but then grew back unevenly and from multiple poles. The C75 spindle phenotype is reminiscent of phenotypes caused by depletion of ch-TOG, a microtubule polymerase, suggesting that C75 blocks microtubule polymerization in metaphase cells. C75 also caused an increase in the number of spindle poles in paclitaxel-treated cells, and combining low amounts of C75 and paclitaxel caused greater regression of multicellular tumour spheroids compared to each compound on their own. These findings warrant further exploration of C75’s anti-cancer potential.


2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Fiorella Ghisays ◽  
Aitor Garzia ◽  
Hexiao Wang ◽  
Claudia Canasto-Chibuque ◽  
Marcel Hohl ◽  
...  

AbstractTelomere repeat containing RNAs (TERRAs) are a family of long non-coding RNAs transcribed from the subtelomeric regions of eukaryotic chromosomes. TERRA transcripts can form R-loops at chromosome ends; however the importance of these structures or the regulation of TERRA expression and retention in telomeric R-loops remain unclear. Here, we show that the RTEL1 (Regulator of Telomere Length 1) helicase influences the abundance and localization of TERRA in human cells. Depletion of RTEL1 leads to increased levels of TERRA RNA while reducing TERRA-containing R loops at telomeres. In vitro, RTEL1 shows a strong preference for binding G-quadruplex structures which form in TERRA. This binding is mediated by the C-terminal region of RTEL1, and is independent of the RTEL1 helicase domain. RTEL1 binding to TERRA appears to be essential for cell viability, underscoring the importance of this function. Degradation of TERRA-containing R-loops by overexpression of RNAse H1 partially recapitulates the increased TERRA levels and telomeric instability associated with RTEL1 deficiency. Collectively, these data suggest that regulation of TERRA is a key function of the RTEL1 helicase, and that loss of that function may contribute to the disease phenotypes of patients with RTEL1 mutations.


2020 ◽  
Vol 1210 ◽  
pp. 128013 ◽  
Author(s):  
Eman S. Tantawy ◽  
Atef M. Amer ◽  
Enaiat K. Mohamed ◽  
Mohamed M. Abd Alla ◽  
Mohamed S. Nafie
Keyword(s):  

2019 ◽  
Author(s):  
Michaela Krafcikova ◽  
Simon Dzatko ◽  
Coralie Caron ◽  
Anton Granzhan ◽  
Radovan Fiala ◽  
...  

High-resolution studies of DNA–ligand interactions in the cellular environment are problematic due to the lack of suitable biophysical tools. To address this issue, we developed an in-cell NMR-based approach for monitoring DNA–ligand interactions inside the nuclei of living human cells. Our method relies on the acquisition of high-resolution NMR data of cells electroporated with pre-formed DNA-ligand complex. The impact of the intracellular environment on the integrity of the complex is assessed on the basis of in-cell NMR signals from unbound and ligand-bound forms of a given DNA target. By using this technique, we studied complexes of model DNA fragments and four ligands, representative of DNA minor-groove binders (netropsin) or ligands binding to DNA pairing defects (naphthalenophanes). We demonstrate that some of the <i>in vitro</i> validated ligands retain their ability to form stable on-target DNA interactions <i>in situ</i>, while other<i> </i>lose this ability due to off-target interactions with genomic DNA as well as cellular metabolic components. Collectively, our data suggest that direct evaluation of behavior of drug-like molecules in the intracellular environment provides important insights for the design and development of DNA-binding ligands with the desired biological action and minimal side effects resulting from off-target binding.<br><div><br></div>


2006 ◽  
Vol 25 (1) ◽  
pp. 9-19 ◽  
Author(s):  
Esther F. A. Brandon ◽  
Rolf W. Sparidans ◽  
Ronald D. van Ooijen ◽  
Irma Meijerman ◽  
Luis Lopez Lazaro ◽  
...  

2004 ◽  
Vol 22 (3) ◽  
pp. 241-251 ◽  
Author(s):  
Esther F. A. Brandon ◽  
Rolf W. Sparidans ◽  
Irma Meijerman ◽  
Ignasio Manzanares ◽  
Jos H. Beijnen ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (10) ◽  
pp. e0139929 ◽  
Author(s):  
Eliška Potůčková ◽  
Jaroslav Roh ◽  
Miloslav Macháček ◽  
Sumit Sahni ◽  
Ján Stariat ◽  
...  

2019 ◽  
Author(s):  
Michaela Krafcikova ◽  
Simon Dzatko ◽  
Coralie Caron ◽  
Anton Granzhan ◽  
Radovan Fiala ◽  
...  

High-resolution studies of DNA–ligand interactions in the cellular environment are problematic due to the lack of suitable biophysical tools. To address this issue, we developed an in-cell NMR-based approach for monitoring DNA–ligand interactions inside the nuclei of living human cells. Our method relies on the acquisition of high-resolution NMR data of cells electroporated with pre-formed DNA-ligand complex. The impact of the intracellular environment on the integrity of the complex is assessed on the basis of in-cell NMR signals from unbound and ligand-bound forms of a given DNA target. By using this technique, we studied complexes of model DNA fragments and four ligands, representative of DNA minor-groove binders (netropsin) or ligands binding to DNA pairing defects (naphthalenophanes). We demonstrate that some of the <i>in vitro</i> validated ligands retain their ability to form stable on-target DNA interactions <i>in situ</i>, while other<i> </i>lose this ability due to off-target interactions with genomic DNA as well as cellular metabolic components. Collectively, our data suggest that direct evaluation of behavior of drug-like molecules in the intracellular environment provides important insights for the design and development of DNA-binding ligands with the desired biological action and minimal side effects resulting from off-target binding.<br><div><br></div>


Sign in / Sign up

Export Citation Format

Share Document